$20.08
At close: May 2 EDT
$20.56
0.482.39%
Pre-Market: 4:58 AM EDT
Comments
Loading...
Apellis Pharmaceuticals Stock Short Interest Report | NASDAQ:APLS | Benzinga
Short interest in Apellis Pharmaceuticals Inc (NASDAQ:APLS) increased during the last reporting period, rising from 22.51M to 26.83M. This put 28.16% of the company's publicly available shares short.
Short interest in Apellis Pharmaceuticals Corp (XNAS:APLS) decreased during the last reporting period, falling from 280.30M to 275.20M. This put 1.17% of the company's publicly available shares short.
Based on the recent average volume of 3.08M shares traded per day, it would take 8.71 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.
Short Interest
26.83M
Short Interest %
28.2%
Days to Cover
8.71
| Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| APLS | Apellis Pharmaceuticals, Inc. | 04/15/2025 | 04/25/2025 | 28.16% | 95,276,723 | 26,833,210 | 3,081,613 | 8.71 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 03/31/2025 | 04/09/2025 | 24.48% | 91,955,446 | 22,511,249 | 2,165,571 | 10.4 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 03/14/2025 | 03/25/2025 | 21.00% | 91,955,446 | 19,313,821 | 1,465,315 | 13.18 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 02/28/2025 | 03/11/2025 | 22.64% | 91,955,446 | 20,815,049 | 1,738,206 | 11.98 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 02/14/2025 | 02/26/2025 | 19.09% | 90,832,650 | 17,341,085 | 1,439,758 | 12.04 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 01/31/2025 | 02/11/2025 | 18.78% | 90,832,650 | 17,055,810 | 1,473,551 | 11.57 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 01/15/2025 | 01/27/2025 | 19.86% | 90,832,650 | 18,039,735 | 2,522,912 | 7.15 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 12/31/2024 | 01/10/2025 | 24.35% | 88,205,961 | 21,477,949 | 2,152,590 | 9.98 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 12/13/2024 | 12/24/2024 | 22.69% | 88,205,961 | 20,011,664 | 3,061,511 | 6.54 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 11/29/2024 | 12/10/2024 | 24.73% | 88,205,961 | 21,811,296 | 4,485,961 | 4.86 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 11/15/2024 | 11/26/2024 | 26.28% | 88,205,961 | 23,182,889 | 4,450,930 | 5.21 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 10/31/2024 | 11/11/2024 | 23.57% | 88,205,961 | 20,786,277 | 2,084,705 | 9.97 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 10/15/2024 | 10/24/2024 | 23.91% | 88,205,961 | 21,088,064 | 3,827,807 | 5.51 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 09/30/2024 | 10/09/2024 | 17.30% | 88,205,961 | 15,260,698 | 2,289,442 | 6.67 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 09/13/2024 | 09/24/2024 | 17.33% | 88,205,961 | 15,284,852 | 1,397,862 | 10.93 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 08/30/2024 | 09/11/2024 | 18.34% | 88,205,961 | 16,173,529 | 826,033 | 19.58 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 08/15/2024 | 08/26/2024 | 18.44% | 88,205,961 | 16,267,681 | 2,141,166 | 7.6 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 07/31/2024 | 08/09/2024 | 18.04% | 88,205,961 | 15,916,603 | 1,373,160 | 11.59 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 07/15/2024 | 07/24/2024 | 17.28% | 87,805,188 | 15,168,402 | 1,352,038 | 11.22 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 06/28/2024 | 07/10/2024 | 16.87% | 87,805,188 | 14,814,085 | 1,802,742 | 8.22 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 06/14/2024 | 06/26/2024 | 15.83% | 87,805,188 | 13,899,907 | 872,302 | 15.93 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 05/31/2024 | 06/11/2024 | 14.94% | 87,805,188 | 13,116,801 | 1,415,017 | 9.27 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 05/15/2024 | 05/24/2024 | 14.33% | 87,805,188 | 12,586,479 | 1,669,061 | 7.54 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 04/30/2024 | 05/09/2024 | 14.11% | 87,805,188 | 12,388,136 | 1,736,373 | 7.13 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 04/15/2024 | 04/24/2024 | 12.16% | 87,733,401 | 10,669,213 | 1,147,476 | 9.3 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 03/28/2024 | 04/09/2024 | 10.05% | 103,890,033 | 10,439,851 | 1,098,740 | 9.5 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 03/15/2024 | 03/26/2024 | 10.19% | 103,890,033 | 10,591,406 | 1,391,553 | 7.61 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 02/29/2024 | 03/11/2024 | 9.69% | 103,890,033 | 10,064,166 | 1,408,971 | 7.14 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 02/15/2024 | 02/27/2024 | 10.09% | 101,808,229 | 10,270,787 | 1,503,091 | 6.83 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 01/31/2024 | 02/09/2024 | 10.48% | 101,808,229 | 10,669,463 | 1,568,794 | 6.8 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 01/12/2024 | 01/24/2024 | 11.82% | 101,808,229 | 12,034,038 | 2,288,740 | 5.26 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 12/29/2023 | 01/10/2024 | 11.48% | 101,808,229 | 11,688,661 | 1,792,077 | 6.52 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 12/15/2023 | 12/27/2023 | 12.75% | 101,808,229 | 12,977,948 | 3,887,528 | 3.34 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 11/30/2023 | 12/11/2023 | 14.99% | 101,808,229 | 15,264,853 | 1,464,068 | 10.43 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 11/15/2023 | 11/27/2023 | 15.85% | 101,808,229 | 16,137,939 | 2,143,822 | 7.53 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 10/31/2023 | 11/09/2023 | 15.94% | 101,808,229 | 16,231,193 | 1,694,169 | 9.58 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 10/13/2023 | 10/24/2023 | 18.40% | 101,045,573 | 18,593,076 | 2,940,235 | 6.32 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 09/29/2023 | 10/10/2023 | 16.60% | 101,045,573 | 16,773,363 | 3,627,479 | 4.62 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 09/15/2023 | 09/26/2023 | 13.47% | 101,045,573 | 13,609,851 | 1,850,811 | 7.35 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 08/31/2023 | 09/12/2023 | 12.18% | 101,045,573 | 12,306,670 | 3,441,592 | 3.58 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 08/15/2023 | 08/24/2023 | 13.60% | 101,045,573 | 13,746,602 | 7,249,918 | 1.9 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 07/31/2023 | 08/09/2023 | 9.50% | 101,045,573 | 9,603,441 | 11,787,236 | 1 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 07/14/2023 | 07/25/2023 | 9.50% | 99,765,292 | 9,482,559 | 791,290 | 11.98 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 06/30/2023 | 07/12/2023 | 9.61% | 99,765,292 | 9,592,108 | 2,624,155 | 3.66 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 06/15/2023 | 06/27/2023 | 11.48% | 99,765,292 | 11,457,348 | 1,134,441 | 10.1 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 05/31/2023 | 06/09/2023 | 11.39% | 99,765,292 | 11,358,371 | 1,236,891 | 9.18 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 05/15/2023 | 05/24/2023 | 11.03% | 99,765,292 | 11,004,915 | 1,798,829 | 6.12 | Get Alert |
| APLS | Apellis Pharmaceuticals, Inc. | 04/28/2023 | 05/09/2023 | 10.31% | 99,765,292 | 10,284,405 | 1,665,213 | 6.18 | Get Alert |
Looking for the most shorted stocks?
